Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013
(1994; 86 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations
Afficher le document1. Summary
Ouvrir ce répertoire et afficher son contenu2. Introduction
Fermer ce répertoire3. Study design and methods
Afficher le document3.1 Outline of the study
Afficher le document3.2 Sampling procedures
Afficher le document3.3 Number and type of samples obtained
Afficher le document3.4 Risk factors for poor drug quality
Afficher le document3.5 Sample storage and laboratory tests
Afficher le document3.6 Data processing and statistical analysis
Afficher le document4. Results
Ouvrir ce répertoire et afficher son contenu5. Discussion
Ouvrir ce répertoire et afficher son contenu6. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuAnnexes
 

3.3 Number and type of samples obtained

881 samples were collected (Table 3).

Expired samples

41 (5%) of the samples collected were expired. These were all facility samples; no GMS samples were expired. Epinephrine injection and ergometrine injection were frequently found expired: these two drugs account for 26 (63%) of all expired samples. Expired samples were tested, but the results were excluded from the analysis.

GMS samples

192 GMS samples were tested. In the case of benzylpenicillin injection no GMS samples were tested. It was assumed that GMS samples for this drug would comply with specifications because the results obtained early in the study showed that all samples in a large number of "worst case" facility samples of benzylpenicillin passed. Only one batch of epinephrine injection was obtained since this drug was out of stock at GMS for most of the study period.

Facility samples

648 facility samples were tested. For those drugs that are only used at hospital level the number of facility samples is much smaller than for those used at both PHC facilities and hospitals (the study area included eight hospitals and over 50 health centres).

Table 3 - Number and type of samples obtained

Drug name

Total samples

Expired samplesa

GMS samples

Facility samples

Longitudinal seriesb

Amoxycillin 250mg caps

35

4

6

25

5

Ampicillin 250mg caps

38

0

10

28

11

Acetylsalicylic acid 300mg tabs

95

0

16

79

39

Doxycycline 100mg caps

25

5

5

15

5

Ferrous sulfate 60mg Fe tabs

104

2

24

78

24

Phenoxymethylpenicillin 250mg tabs

73

0

14

59

7

Tetracycline 250mg caps

102

0

36

66

31

Retinol 25-50,000 IU tabs

56

0

5

51

30

Epinephrine 1:1000 inj

25

14

1

10

4

Ampicillin 500mg inj

38

2

10

26

13

Benzylpenicillin 5MU inj

45

2

0

43

0

Ergometrine 0.5mg/ml inj

128

12

34

82

53

Procaine penicillin 300mg/ml inj

103

0

31

72

42

TOTAL:

881

41

192

648

264

Note:

a Samples past their expiry date are recorded here but results have been excluded or presented separately.

b The longitudinal series is a subgroup of facility samples where the sample has the same batch number as GMS,

Longitudinal series

This is a data set in which GMS and facility samples are taken from the same batch. The results from these facility/GMS sample pairs were analysed and reported separately, 264 facility samples could be paired with GMS samples of the same batch.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013